Factors associated with deferral or non-performance of an organized breast cancer screening program during the COVID-19 pandemic in France

IF 2.9 2区 医学 Q2 ONCOLOGY
Cancer Medicine Pub Date : 2024-08-27 DOI:10.1002/cam4.7444
Jean Papadacci Stephanopoli, Leila Bouazzi, Myriam Guerbaz-Sommi, Olivier Graesslin, Aline Hurtaud, Salvatore Ilardo, Jan Chrusciel, Cécile Barbaret, Camille Bertrand, Stéphane Sanchez
{"title":"Factors associated with deferral or non-performance of an organized breast cancer screening program during the COVID-19 pandemic in France","authors":"Jean Papadacci Stephanopoli,&nbsp;Leila Bouazzi,&nbsp;Myriam Guerbaz-Sommi,&nbsp;Olivier Graesslin,&nbsp;Aline Hurtaud,&nbsp;Salvatore Ilardo,&nbsp;Jan Chrusciel,&nbsp;Cécile Barbaret,&nbsp;Camille Bertrand,&nbsp;Stéphane Sanchez","doi":"10.1002/cam4.7444","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Delays in detection and treatment of breast cancer can lead to increased mortality. To date, participation in organized breast cancer screenings (OBCS) has been suboptimal worldwide. The objective of this study was to investigate the factors associated with deferral or non-performance of mammography during the COVID-19 pandemic for women who had previously participated in OBCS.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A retrospective observational study was conducted on a cohort of 6282 women from the Aube Department of France, who were invited to an OBCS in 2020. Participants were divided into women who promptly underwent screening after receiving an invitation (between 22 and 25 months elapsed since the last mammogram), women who underwent late screening (≥26 months since the last mammogram), and those who were never screened. Data were collected from a self-reported questionnaire. Comparative and multivariable analyses modeling the probability of each type of attendance were performed using these data.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>In total, 2301 women (aged 50–74 years) returned a valid questionnaire. Compared to women who promptly underwent mammography, non- and late-screening participants were younger, had less frequent gynecological follow-up and a less frequent history of colorectal cancer screening. Women with higher education status and those residing in socially disadvantaged areas were more likely to attend late.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The absence of regular gynecological follow-up and the absence of colorectal cancer screening were significant factors associated with deferral of or non-attendance at OBCS.</p>\n </section>\n </div>","PeriodicalId":139,"journal":{"name":"Cancer Medicine","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.7444","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cam4.7444","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Delays in detection and treatment of breast cancer can lead to increased mortality. To date, participation in organized breast cancer screenings (OBCS) has been suboptimal worldwide. The objective of this study was to investigate the factors associated with deferral or non-performance of mammography during the COVID-19 pandemic for women who had previously participated in OBCS.

Methods

A retrospective observational study was conducted on a cohort of 6282 women from the Aube Department of France, who were invited to an OBCS in 2020. Participants were divided into women who promptly underwent screening after receiving an invitation (between 22 and 25 months elapsed since the last mammogram), women who underwent late screening (≥26 months since the last mammogram), and those who were never screened. Data were collected from a self-reported questionnaire. Comparative and multivariable analyses modeling the probability of each type of attendance were performed using these data.

Results

In total, 2301 women (aged 50–74 years) returned a valid questionnaire. Compared to women who promptly underwent mammography, non- and late-screening participants were younger, had less frequent gynecological follow-up and a less frequent history of colorectal cancer screening. Women with higher education status and those residing in socially disadvantaged areas were more likely to attend late.

Conclusion

The absence of regular gynecological follow-up and the absence of colorectal cancer screening were significant factors associated with deferral of or non-attendance at OBCS.

Abstract Image

法国在 COVID-19 大流行期间推迟或不执行有组织乳腺癌筛查计划的相关因素。
背景:乳腺癌检测和治疗的延误会导致死亡率上升。迄今为止,全世界参加有组织的乳腺癌筛查(OBCS)的人数一直不理想。本研究的目的是调查在 COVID-19 大流行期间,曾参加过 OBCS 的妇女推迟或未进行乳房 X 射线照相术的相关因素:这项回顾性观察研究的对象是法国奥布省(Aube Department of France)的 6 282 名妇女,她们在 2020 年应邀参加了 OBCS。参与者被分为收到邀请后立即接受筛查的女性(距上次乳房X光检查时间在22至25个月之间)、接受晚期筛查的女性(距上次乳房X光检查时间≥26个月)以及从未接受筛查的女性。数据通过自我报告问卷收集。利用这些数据对每种类型的就诊概率进行了比较和多变量分析建模:共有 2301 名妇女(50-74 岁)交回了有效问卷。与及时接受乳腺 X 射线照相术的妇女相比,未接受筛查和逾期接受筛查的妇女更年轻,接受妇科随访的次数更少,接受结肠直肠癌筛查的次数也更少。教育程度较高的妇女和居住在社会贫困地区的妇女更有可能晚接受检查:结论:没有定期妇科随访和没有接受过结直肠癌筛查是导致推迟或不参加 OBCS 的重要因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Medicine
Cancer Medicine ONCOLOGY-
CiteScore
5.50
自引率
2.50%
发文量
907
审稿时长
19 weeks
期刊介绍: Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas: Clinical Cancer Research Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations Cancer Biology: Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery. Cancer Prevention: Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach. Bioinformatics: Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers. Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信